Skip to main content
← Transaction feed

Source-linked transaction record

Rep. Jonathan Jackson filing: Joint sale of $REGN on Nov 13, 2024

Rep. Jonathan Jackson's filing reports that a joint account sold Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) for the reported amount of $15,001 – $50,000. The filing identifies the account owner as joint.

What the filing reports

Account owner
Joint
Transaction
sale
Reported amount
$15,001 – $50,000
Transaction date
Nov 13, 2024
Notice date
Dec 3, 2024
Filing date
Dec 12, 2024
Filing timing
29 days to file
Filed ticker
$REGN
House document
20026313
Filing year
2024

Disclosures are reported transactions, not verified real-time portfolio holdings.

Same source document

Other transactions in this filing

View the complete filing →

Continue researching

More disclosures from Jonathan Jackson

Open member history →
Relevant OurElectedNews.com reporting ↗